Purification and characterization of a Mg2+-dependent endonuclease (AN34) from etoposide-treated human leukemia HL-60 cells undergoing apoptosis

Cancer Research

Volumn 58, Issue 12, 1998, Pages 2576-2582

  Yoshida, Akira ^b   Pourquier, Philippe ^b   Pommier, Yves ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; DNA FRAGMENT; ENDONUCLEASE; ENZYME INHIBITOR; ETOPOSIDE; MAGNESIUM; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; UNCLASSIFIED DRUG; ACTIN; ANTINEOPLASTIC AGENT; APOPTOTIC NUCLEASE MR 34,000; DEOXYRIBONUCLEASE; DEOXYRIBONUCLEASE I; N ETHYLMALEIMIDE; TUMOR PROTEIN; VIRUS DNA;

APOPTOSIS; ARTICLE; CHROMATIN; CONTROLLED STUDY; DNA STRAND BREAKAGE; ENZYME ACTIVITY; ENZYME PURIFICATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; CELL STRAIN HL 60; DNA DAMAGE; DRUG EFFECT; ENZYMOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; SIMIAN VIRUS 40;

ACTINS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; DEOXYRIBONUCLEASE I; DNA DAMAGE; DNA FRAGMENTATION; DNA, VIRAL; ENDODEOXYRIBONUCLEASES; ENDONUCLEASES; ENZYME INHIBITORS; ETHYLMALEIMIDE; ETOPOSIDE; HL-60 CELLS; HUMANS; NEOPLASM PROTEINS; SIMIAN VIRUS 40;

EID: 0032525332     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Wyllie, A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Lond.), 284: 555-556, 1980.
2. Wyllie, A. H. The genetic regulation of apoptosis. Curr. Opin. Genet. Dev., 5: 97-104, 1995.
3. Arends, M. J., Morris, R. G, and Wyllie, A. H. Apoptosis: the role of the endonuclease. Am. J. Pathol., 136: 593-608, 1990.
4. Wyllie, A. H., Kerr, J. F. R., and Currie, A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol., 68: 251-306, 1980.
5. Peitsch, M. C., Polzar, B., Stephan, H., Crompton, T., MacDonald H. R., Mannherz H. G., and Tschopp, J. Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis. (programmed cell death). EMBO J., 12: 371-377, 1993.
6. Gaido, M. L., and Cidlowski, J. A. Identification, purification, and characterization of a calcium dependent endonuclease (NUC 18) from apoptotic rat thymocytes. NUC18 is not histone H2B. J. Biol. Chem., 266: 18580-18585, 1991.
7. Barry, A., and Eastman, A. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Arch. Biochem. Biophys., 300: 440-450, 1993.
8. 2+-dependent endonuclease from human spleen: purification, properties, and role in apoptosis. Biochemistry, 32: 9129-9136, 1993.
9. 2+-dependent endonuclease associated with apoptosis. J. Immunol., 156: 922-931, 1996.
10. Pandey, S., Walker, P. R., and Sikorska, M. Identification of a novel 97 kDa endonuclease capable of internucleosomal DNA cleavage. Biochemistry, 36: 711-720, 1997.
11. Shiokawa, D., Ohyama, H., Yamada, T., and Tanuma, S. Purification and properties of DNase γ from apoptotic rat thymocytes. Biochem. J., 326: 675-681, 1997.
12. 2+ concentration. Arch. Biochem. Biophys., 269: 365-370, 1989.
13. 2+-mediated endonuclease activation. Science (Washington DC), 242: 256-259, 1988.
14. 2+ are not required to trigger apoptosis in human leukaemia cells. Clin. Exp. Immunol., 87: 465-471, 1992.
15. Barry, M. A., Reynolds, J. E., and Eastman, A. Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res., 53: 2349-2357, 1993.
16. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (Lond.), 371: 346-347, 1994.
17. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T. T., Yu, V. L., and Miller, D. K. Identification and inhibition of ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376: 37-43, 1995.
18. Martin, S. J., Newmeyer, D. D., Mathias, S., Farschon, D. M., Wang, H. G., Reed, J. C., Kolesnick, R. N., and Green, D. R. Cell-free reconstitution of Fas-, UV radiation-and ceramide-induced apoptosis. EMBO J., 14: 5191-5200, 1995.
19. Dubrez, L., Savoy, I., Hamman, A., and Solary, E. Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J., 15: 5504-5512, 1996.
20. Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature (Lond.), 391: 43-50, 1998.
21. Patel, T., Gores, G. J., and Kaufman, S, H. The role of proteases during apoptosis. FASEB J., 10: 587-597, 1996.
22. Martin, S. J., and Green, D, R. Protease activation during apoptosis: death by a thousand cuts? Cell: 82:349-352, 1995.
23. Kaufmann, S. H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res., 49: 5870-5878, 1989.
24. Bertrand, R., Sarang, M., Jenkins, J. Kerrigan, D., and Pommier, Y. Differential induction of secondary fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res., 51: 6280-6285, 1991.
25. Solary, E., Bertrand, R., Kohn, K. W., and Pommier, Y. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood, 81: 1359-1368, 1993.
26. Martin, S. J., Lennon, S. V., Bonham, A. M., and Cotter, T. G. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J. Immunol., 145: 1859-1867, 1990.
27. Shao, R. G., Shimizu, T., and Pommier, Y. 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53. Exp. Cell Res., 234: 388-397, 1997.
28. Rauch, F., Polzar, B., Stephan, H., Zanotti, S., Paddenberg, R., and Mannherz, H. G. Androgen ablation leads to an upregulation and intranuclear accumulation of deoxyribonuclease I in rat prostate epithelial cells paralleling their apoptotic elimination J. Cell Biol., 137: 909-923, 1997.
29. Goelz, S. E., Hamilton, S. R., and Vogelstein, B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem. Biophys. Res. Commun., 130: 118-126, 1985.
30. Bruno, S., Dell Bino, G., Lassota, P., Giaretti, W., and Darzynkiewicz, Z. Inhibitors of proteases prevent endonucleolysis accompanying apoptotic death of HL-60 leukemic cells and normal thymocytes. Leukemia (Baltimore), 6: 1113-1120, 1992.
31. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., and Poirier, G. G. Specific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res., 53: 3976-3985, 1993.
32. Wright, S. C., Wei, Q. S., Zhong, J., Zheng, H., Kinder, D. H., and Larrick, J. W. Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation. J. Exp. Med., 180: 2113-2123, 1994.
33. Chow, S. C., Weis, M., Kass, G. E., Holmstrom, T. H., Eriksson, J. E., and Orrenius, S. Involvement of multiple proteases during Fas-mediated apoptosis in T lymphocytes. FEBS Lett., 364: 134-138, 1995.
34. Mansat, V., Bettaieb, A., Levade, T., Laurent, G., and Jaffrezou, J. P. Serine protease inhibitors block neutralsphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. FASEB J., 11: 695-702, 1997.
35. MacFarlane, M., Cain, K., Sun, X, M., Alnemri, E. S., and Cohen, G. M. Processing/ activation of at least four interleukin-1β converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells. J. Cell Biol., 137: 469-479, 1997.
36. Lazarides, E., and Lindberg, U. Actin is the naturally occurring inhibitor of deoxyribonuclease I. Proc. Natl. Acad. Sci. USA, 71: 4742-4746, 1974.
37. Gavrieli, Y., Sherman, Y., and Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
38. Peitsch, M. C., Muller, C., and Tschopp, J. DNA fragmentation during apoptosis is caused by frequent single-strand cuts. Nucleic Acids Res., 21: 4206-4209, 1993.
39. Walker, P. R., Leblanc, J., and Sikorska, M. Evidence that DNA fragmentation in apoptosis is initiated and propagated by single-strand breaks. Cell Death Differ., 4: 506-515, 1997.
40. + efflux in the activation of apoptosis. J. Biol. Chem., 272: 32436-32442, 1997.
41. + suppresses the activation of apoptosis in lymphocytes. J. Biol. Chem., 272: 30567-30576, 1997.
42. Lacks, S. A. Deoxyribonuclease I in mammalian tissues. Specificity of inhibition by actin. J. Biol. Chem., 256: 2644-2648, 1981.
43. Nakayama, J., Fujiyoshi, T., Nakamura, M., and Anai, M. Purification and properties of an endodeoxyribonuclease from nuclei of bovine small intestinal mucosa. J. Biol. Chem., 256: 1636-1642, 1981.
44. Tsuruo, T., Arens, M., Padmanabhan, R., and Green, M. An endodeoxyribonuclease of human KB cells. Purification and properties of the enzyme. J. Biol. Chem., 253: 3400-3407, 1978.
45. Hibino, Y., Yoneda, T., and Sugano, N. Purification and properties of a magnesium-dependent endodeoxyribonuclease endogenous to rat-liver nuclei. Biochim. Biophys. Acta, 950: 313-320, 1988.
46. Bernardi, G. Mechanism of action and structure of acid deoxyribonuclease. Adv. Enzymol., 31: 1-7, 1968.
47. Reynolds, J. E., Wolf, C. M., and Eastman, A. Intracellular acidification is associated with, but not required for caspase activation, DNA fragmentation or apoptosis. Int. J. Oncol., 11: 1241-1246, 1997.
48. Sakahira, H., Enari, M., and Nagata, S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature (Lond.), 391: 96-99, 1998.